Government of CanadaPublic Health Agency of Canada / Agency de la santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors HealthSurveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

[Table of Contents]

 

 

Canada Communicable Disease Report - Supplement
Volume: 23S8
December 1997

INFECTION CONTROL GUIDELINES

Preventing Infections Associated with Indwelling Intravascular Access Devices

Bibliography

  1. Health and Welfare Canada. Infection control guidelines. Section I: prevention of intravascular infections. 1990:1-11.

  2. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FA, editors. Infections associated with indwelling medical devices. 2nd ed. Washington, DC: American Society for Microbiology Press, 1994:155-212.

  3. Haley RW, Culver DH, White JW et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.

  4. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992;15:197-210.

  5. Liñares J, Sitges-Serra A, Garau J et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985;21:357-60.

  6. Sitges-Serra A, Puig P, Liñares J. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative Staphylococci during parenteral nutrition. J Parenter Enteral Nutr 1984;8:668-72.

  7. Salzman MB, Isenberg HD, Shapiro JF et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993;167:487-90.

  8. Raad I, Costerton W, Sabharwal U et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993;168:400-07.

  9. Canadian Advisory Committee on the Home IV Antibiotic Therapy. Highlights of a consensus conference, November, 11-13. Toronto: Hoffman La Roche.

  10. Sanderson I, Deitel M. Intravenous hyperalimentation without sepsis. Surg Gynecol Obstet 1973;136:577-85.

  11. Ryan JA, Abel RM, Abbott WM et al. Catheter complications in total parenteral nutrition. N Engl J Med 1974;290:757-61.

  12. Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition. Am J Surg 1976;132:214-20.

  13. Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. J Parenter Enteral Nutr 1987;11:190-201.

  14. Graham D, Keldermans MM, Klemm LW et al. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 1991;91:95s-100s.

  15. Widmer AF. IV-related infections. In: Wenzel RP, editor. Prevention and control of nosocomial infections. Baltimore: Williams & Wilkins, 1993:556-79.

  16. Maki DG. Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994;15:227-30.

  17. Tomford JW, Hershey CO, McLaren CE et al. Intravenous therapy team and peripheral venous catheter-associated complications: a prospective control study. Arch Intern Med 1984;144:1191-94.

  18. Seaman M, Lammers R. Inability of patients to self-diagnose wound infections. J Emerg Med 1991;9:215-19.

  19. Martone WJ, Gaynes RP, Horan TC et al. Nosocomial infection rates for inter hospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991;12:609-21.

  20. Sheth NK, Franson TR, Rose HD et al. Colonization of bacteria on polyvinyl chloride and teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983;18:1061-63.

  21. Hogt AH, Dankert J, Feifen J. Encapsulation, slime production and surface hydrophobicity of coagulase-negative staphylococci. FEMS Microbiol Lett 1983;18:211-15.

  22. Ashkenazi S, Weiss E, Drucker MM. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity. J Lab Clin Med 1986;107:136-40.

  23. Stillman RM, Soliman F, Garcia L et al. Etiology of catheter-associated sepsis: correlation with thrombogenicity. Arch Surg 1977;112:1497-502.

  24. McCarthy MC, Shives JK, Robison RJ et al. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. J Parenter Enteral Nutr 1987;11:259-62.

  25. Farkas JC, Liu N, Bleriot JP et al. Single-versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med 1992;93:277-82.

  26. Clark-Christoff N, Watters VA, Sparks W et al. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Enteral Nutr 1992;16:403-07.

  27. Kamal GD, Pfaller MA, Rempe LE et al. Reduced intravascular catheter infection by antibiotic bonding. JAMA 1991;265:2364-68.

  28. Cappello M, DePauw L, Bastin G et al. Central venous access for haemodialysis using the Hickman catheter. Nephrol Dial Transplant 1989;4:988-92.

  29. Maki DG, Cobb L, Garman JK et al. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988;85:307-14.

  30. Flowers RH, Schwenzer KJ, Kopel RF et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA 1989;261:878-83.

  31. Syndman DR, Murray SA, Kornfeld SJ et al. Total parenteral nutrition-related infections: prospective epidemiologic study using semiquantitative methods. Am J Med 1982;73:695-99.

  32. Mitchell A, Atkins S, Royle GT et al. Reduced catheter sepsis and prolonged catheter life using a tunnelled silicone rubber catheter for total parenteral nutrition. Br J Surg 1982;69:420-22.

  33. Mermel LA, Stoiz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis 1993;167:920-24.

  34. Henderson DK. Bacteremia due to percutaneous intravascular devices. In: Mandell G, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone Inc., 1995:2587-99.

  35. Moss AH, Vasilakis C, Holley JL et al. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for haemodialysis patients. Am J Kid Dis 1990;16:211-15.

  36. Wurzel CL, Halom K, Feldman JG et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536-40.

  37. Brincker H, Saeter G. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer 1986;57:1124-29.

  38. Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994;15:315-18.

  39. Thomas F, Burke JP, Parker J et al. The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med 1983;11:807-12.

  40. Richet H, Hubert B, Nitemberg G et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990;28:2520-25.

  41. Mermel LA, McCormick RD, Springman SR et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991;91:197-205.

  42. Senagore A, Waller JD, Bonnell BW et al. Pulmonary artery catheterization: a prospective study of internal jugular and subclavian approaches. Crit Care Med 1987;15:35-7.

  43. Doebbeling BN, Stanley GL, Sheetz CT et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88-93.

  44. Larson E, Mayur K, Laughon BA. Influence of two hand washing frequencies on reduction in colonizing flora with three hand washing products used by health care personnel. Am J Infect Control 1989;17:83-8.

  45. Raad II, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-38.

  46. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991;338:339-43.

  47. Casewell MW, Law MM, Desai N. A laboratory model for testing agents for hygienic hand disinfection: hand washing and chlorhexidine for the removal of Klebsiella. J Hosp Infect 1988;12:163-75.

  48. Wade JJ, Desai N, Casewell MW. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae. J Hosp Infect 1991;18:211-18.

  49. Garland JS, Buck RK, Maloney P et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995;14:510-16.

  50. Rannen T, Ladefoged K, Hegnhoj J et al. Catheter-related sepsis in long-term parenteral nutrition with broviac catheters: an evaluation of different disinfectants. Clin Nutr 1990;9:131-36.

  51. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981;70:739-44.

  52. Donowitz LG. Benzalkonium chloride is still in use. Infect Control Hosp Epidemiol 1991;12:186-87.

  53. Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure. Am J Med 1987;38:833-40.

  54. Band JD, Maki DG. Infections caused by arterial catheters used for hemodynamic monitoring. Am J Med 1979;67:735-41.

  55. Bauer E, Densen P. Infections from contaminated Elastoplast®. N Engl J Med 1979;15:370.

  56. Oldman P. A sticky situation? Microbiological study of adhesive tape used to secure IV cannulae. Prof Nurse 1991;6:265-69.

  57. Levin A, Mason AJ, Jindel KK et al. Prevention of haemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int Suppl 1991;40:934-38.

  58. Mermel LA, Maki DG. Infectious complications of swan-Ganz pulmonary artery catheters: pathogenesis, epidemiology, prevention, and management. Am J Respir Crit Care Med 1994;149:1020-36.

  59. Aly R, Bayles C, Maibach H. Restriction of bacterial growth under commercial catheter dressings. Am J Infect Control 1988;16:95-100.

  60. Hoffmann KK, Western SA, Kaiser DL et al. Bacterial colonization and phlebitis-associated risk with transplant polyurethane film for peripheral intravenous site dressings. Am J Infect Control 1988;16:101-06.

  61. Hoffmann KK, Weber DJ, Samsa GP et al. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA 1992;267:2072-76.

  62. Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989;159:310-19.

  63. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. JAMA 1987;258:2396-403.

  64. Maki DG, Stolz SS, Wheeler S et al. A prospective randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994;22:1729-37.

  65. Birnbaum DW. Safety of maintaining intravenous sites for longer than 48 hours. J Clin Microbiol 1981;13:833-35.

  66. Garland JS, Nelson DB, Cheah TE et al. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis 1987;6:918-21.

  67. Garland JS, Dunne MJ, Havens P et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992;89:1145-50.

  68. Furfaro S, Gauthier M, Lacroix J et al. Arterial catheter-related infections in children: a 1-year cohort analysis. Am J Dis Child 1991;145:1037-42.

  69. Stenzel JP, Green TP, Fuhrman BP et al. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complications. Crit Care Med 1989;17:984-88.

  70. Cobb DK, High KP, Sawyer RG et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:1062-68.

  71. Bozzetti F, Terno G, Bonfanti G et al. Prevention and treatment of central venous catheter sepsis by exchange via a guide wire: a prospective controlled trial. Ann Surg 1983;198:48-52.

  72. Powell C, Kudsk KA, Kulich PA et al. Effect of frequent guide wire changes on triple-lumen catheter sepsis. J Parenter Enteral Nutr 1988;12:462-64.

  73. Eyer S, Brummitt C, Crossley K et al. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990;18:1073-79.

  74. Smith I, Hathaway M, Goldman C et al. A randomized study to determine complications associated with duration of insertion of heparin locks. Res Nurs Health 1990;13:367-73.

  75. White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control 1994;22:231-35.

  76. Raad I, Umphrey J, Khan A et al. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect 1993;23:17-26.

  77. Viall CD. Daily access of implanted venous ports: implications for patient education. J Intraven Nurs 1990;13:294-96.

  78. Landers S, Moise AA, Fraley JK et al. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child 1991;145:675-80.

  79. Center for Disease Control. The infection hazards of pressure monitoring devices. National Nosocomial Infections Study Report, Annual Summary 1974. 1977; March:15-21.

  80. Beck-Sague CM, Jarvis WR. Epidemic bloodstream infections associated with pressure transducers: a persistent problem. Infect Control Hosp Epidemiol 1989;10:54-59.

  81. Keeler C, McLane C, Covey M et al. A review of infection control practices related to intravascular pressure monitoring devices (1975-1985). Heart Lung 1987;16:201-06.

  82. Danzig LE, Short LJ, Collins K et al. Bloodstream infections associated with a needle less intravenous infusion system in patients receiving home infusion therapy. JAMA 1995;273:1862-64.

  83. Chodoff A, Pettis AM, Schoonmaker D et al. Polymicrobial gram-negative bacteremia associated with saline solution flush used with a needle less intravenous system. Am J Infect Control 1995;23:357-63.

  84. Buxton AE, Highsmith AK, Garner JS et al. Contamination of intravenous infusion fluid: effects of changing administration sets. Ann Intern Med 1979;90:764-68.

  85. Josephson A, Gombert ME, Sierra MF et al. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985;6:367-70.

  86. Maki DG, Botticelli JT, LeRoy ML et al. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA 1987;258:1777-81.

  87. Snydman DR, Donnelly-Reidy M, Perry LK et al. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987;8:113-16.

  88. Rudnick JR, Beck-Sague C, Anderson RL et al. Gram-negative bacteremia in open-heart-surgery patients traced to probable tap-water contamination of pressure-monitoring equipment. Infect Control Hosp Epidemiol 1996;17:281-85.

  89. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 1988;9:154-58.

  90. Shinozaki T, Deane RS, Mazuzan JEJ et al. Bacterial contamination of arterial lines: a prospective study. JAMA 1983;249:223-25.

  91. Snydman DR, Hindman SH, Wineland MD et al. Nosocomial viral hepatitis B: a cluster among staff with subsequent transmission to patients. Ann Intern Med 1976;85:573-77.

  92. Panlilio AL, Beck-Sague CM, Siegel JD et al. Infections and pseudo infections due to povidone-iodine solution contaminated with Pseudomonas cepacia. Clin Infect Dis 1992;14:1078-83.

  93. Health Canada. Infection control guidelines for cleaning, disinfection, sterilization and antisepsis in health care. 1998. (in press).

  94. Stotter AT, Ward H, Waterfield AH et al. Junctional care: the key to prevention of catheter sepsis in intravenous feeding. J Parenter Enteral Nutr 1987;11:159-62.

  95. Segura M, Alia C, Valverde J et al. Assessment of a new hub design and the semiquantitative catheter culture method using an in vivo experimental model of catheter sepsis. J Clin Microbiol 1990;28:2551-54.

  96. Inoue Y, Nezu R, Matsuda H et al. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. J Parenter Enteral Nutr 1992;16:581-85.

  97. Jackson D. Latex allergy and anaphylaxis: what to do? J Intraven Nurs 1995;18:33-52.

  98. Simmons B. Alternative to IV filter usage. Infect Control 1985;6:342,344 (letters).

  99. Birnhaum D, Gurevich I. More comments on IV filter debate. Infect Control Hosp Epidemiol 1988;9:143.

  100. O'Malley MK, Rhame FS, Cerra FB et al. Value of routine pressure monitoring system changes after 72 hours of continuous use. Crit Care Med 1994;22:1424-30.

  101. Solomon SL, Alexander H, Eley JW et al. Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis 1986;5:680-85.

  102. Weems Jr JJ, Chamberland ME, Ward J et al. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987;25:1029-32.

  103. Villarino ME, Jarvis WR, O'Hara C et al. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol 1989;27:2433-36.

  104. Beck-Sague CM, Jarvis WR, Brook JH et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 1990;132:723-33.

  105. Ransjo U, Good Z, Jalakas K et al. An outbreak of Klebsiella oxytoca septicemias associated with the use of invasive blood pressure monitoring equipment. ACTA Anaesthesiol Scand 1992;36:289-91.

  106. Armour NK, Henderson WD. Alcohol spray versus wipes in disinfecting vial diaphragms. Am J Hosp Pharm 1982;39:123.

  107. Weil DC, Arnow PM. Safety of refrigerated storage of admixed parenteral fluid. J Clin Microbiol 1988;26:1787-90.

  108. Stamm WE, Colella JJ, Anderson RL et al. Indwelling arterial catheters as a source of nosocomial bacteremia: an outbreak caused by Flavobacterium species. N Engl J Med 1975;292:1099-102.

  109. Lacey S, Want SV. Pseudomonas pickettii infections in a paediatric oncology unit. J Hosp Infect 1991;17:45-51.

  110. Pegues DA, Carson LA, Anderson RL et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis 1993;16:407-11.

  111. Sherertz RJ, Gledhill KS, Hampton KD et al. Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. J Pediatr 1992;120:455-61.

  112. Fan ST, Teoh-Chan CH, Lau KF et al. Predictive value of surveillance skin and hub cultures in central venous catheters sepsis. J Hosp Infect 1988;12:191-98.

  113. Sitges-Serra A, Liñares J, Brun-Buisson C et al. Limitations of semiquantitative method for catheter culture (letters). J Clin Microbiol 1988;26:1074-76.

  114. Widmer AF, Nettleman M, Flint K et al. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med 1992;152:1299-302.

  115. Health and Welfare Canada. Infection control guidelines. Section II: prevention of surgical wound infections. 1990:13-25.

  116. Health and Welfare Canada. Infection control guidelines. Section V: hospital environmental control. 1990:63-85.

  117. Health Canada. Evidence-based medicine. CCDR 1994;20:145-56.

  118. Jarvis WR, Edwards JR, Culver DH et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med 1991;91:185-91.

  119. Couchonnal GJ, Hodges GR, Barnes WG et al. Complication with heparin-lock needles. JAMA 1979;242:2098-100.

  120. Nelson DB, Garland JS. The natural history of teflon catheter-associated phlebitis in children. Am J Dis Child 1987;141:1090-92.

  121. Tully JL, Friedland GH, Baldini LM et al. Complications of intravenous therapy with steel needles and teflon catheters: a comparative study. Am J Med 1981;70:702-06.

  122. Hodder SL, Stern RC. Brief clinical and laboratory observations: safety of long duration intravenous heparin- lock needles for administration of antibiotics to cystic fibrosis patients. J Pediatr 1981;99:312-14.

  123. Cheesebrough JS, Finch RG, MacFarlane JT. The complications of intravenous cannulae incorporating a valved injection side port. J Hyg Camb 1984;93:497-504.

  124. Gantz NM, Presswood GM, Goldberg R et al. Effects of dressing type and change interval on intravenous therapy complication rates. Diagn Microbiol Infect Dis 1984;2:325-32.

  125. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991;114:845-54.

  126. Band JD, Maki DG. Steel needles used for intravenous therapy: morbidity in patients with hematologic malignancy. Arch Intern Med 1980;140:31-4.

  127. Russel JA, Joel M, Hudson RJ et al. Prospective evaluation of radial and femoral artery catheterization sites in critically ill adults. Crit Care Med 1983;11:936-39.

  128. Norwood SH, Cormier B, McMahon NG et al. Prospective study of catheter-related infection during prolonged arterial catheterization. Crit Care Med 1988;16:836-39.

  129. National Nosocomial Infections Surveillance System. National nosocomial infections surveillance (NNIS) semiannual report, May 1995. Am J Infect Control 1995;23:377-85.

  130. Gaynes RP, Martone WJ, Culver DH et al. Comparison of rates of nosocomial infections in neonatal intensive care unit in the United States. Am J Med 1991;91:192-96.

  131. Pyzdek T. Pyzdek's guide to SPC. v. Volume One: Fundamentals. Tucson, AZ: Quality America, 1989.

  132. Birnbaum D. CQI tools: sentinel events, warning, and action limits. Infect Control Hosp Epidemiol 1993;14:537-39.

  133. Deming WE. Out of the crisis. Cambridge, MA: Massachusetts Institute of Technology, Centre for Advanced Engineering Study, 1986.

  134. Benneyan JC, Kaminsky FC. Modeling discrete data in SPC: The g and h control charts. American Society For Quality Control Annual Quality Congress Transactions 1994:32-42.

 

[Previous] [Table of Contents] [Next]
Last Updated: 2002-11-08 Top
Important Notices